Biotech

Page 18 of 19

J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

After Allergan loss, is Valeant dumpster diving?

By
January 31, 2015
A powerful new super antibiotic may be right under our feet

A powerful new super antibiotic may be right under our feet

By
January 8, 2015
The $3 billion startup that wants to help you to make medicines in your own body

The $3 billion startup that wants to help you to make medicines in your own body

By
January 8, 2015
Davos World Economic Forum (WEF) 2011
Leadership

Sean Parker gives $24 million to Stanford to cure allergies

By
December 17, 2014
2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech
Finance

2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech

By Jen Wieczner and Lauren Silva Laughlin
December 4, 2014
Daniel Loeb urges Amgen to split into two companies
Finance

Daniel Loeb urges Amgen to split into two companies

By
October 21, 2014
Michelle Dipp, CEO Of OvaScience
MPW

OvaScience CEO talks Apple, Facebook and the $9 billion fertility market

By
October 16, 2014
How to stop Ebola
Features

How to stop Ebola

By
September 4, 2014
Catalent delivers with $871 million biotech IPO
Finance

Catalent delivers with $871 million biotech IPO

By
July 31, 2014
Wall Street’s next bet: Cures for rare diseases
Features

Wall Street’s next bet: Cures for rare diseases

By
January 21, 2014
The big bull backup
Features

The big bull backup

By
September 19, 2013
Fortune
Finance

Lessons from the frontlines of early-stage biotech investing

By
February 12, 2013
Fortune

Stem cell dollars: California leads the way

By Fortune Editors, Brett Krasnove and Brett Krasnove
September 28, 2012
Fortune

Advanced prosthetics are about to transform sport

By
August 29, 2012
Fortune
Finance

‘Premature scaling’ in biotech

By
September 6, 2011

Most Popular